We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Saliva Test Could Identify People Genetically Susceptible to Type 2 Diabetes

By LabMedica International staff writers
Posted on 08 Jul 2025

Type 2 diabetes is a chronic condition that arises when the body struggles to produce insulin or the cells fail to respond to it properly, causing high blood sugar levels. More...

As diabetes becomes more prevalent, early detection and prevention are crucial. However, diagnosing the disease early can be difficult. One area that has been questioned is the role of salivary amylase, an enzyme that breaks down starch into sugars. More copies of the AMY1 gene, which expresses salivary amylase, may result in more enzyme production. The relationship between AMY1 gene copy number and diabetes risk is not fully understood, and there is a need for further exploration. Now, new research suggests that higher AMY1 gene copies may have a protective effect against Type 2 diabetes, though more long-term studies are needed to confirm this. If researchers ultimately establish a clear association between AMY1 copy number and diabetes, it could pave the way for genetically testing people at birth to predict their susceptibility to the disease.

A study by researchers at Cornell University (Ithaca, NY, USA) aimed to clarify the connection between the AMY1 gene copy number and diabetes risk. The researchers investigated the role of AMY1 gene copy number in the activity of salivary amylase and its potential link to Type 2 diabetes. The team conducted measurements of amylase activity in participants during early morning and evening, discovering significant differences between the two times. The findings highlighted a diurnal effect, meaning that amylase activity fluctuates throughout the day, regardless of AMY1 gene copy number. The researchers speculated that those with higher AMY1 copy numbers might experience an early insulin response when starches are broken down, offering a possible protective effect against Type 2 diabetes.

The study, published in PLOS One, confirmed that individuals with Type 2 diabetes or prediabetes exhibited higher salivary amylase activity with each additional AMY1 gene copy. This was even true among participants with the same number of AMY1 gene copies, suggesting that amylase activity could be a contributing factor to the disease. The researchers suspect that those with lower AMY1 copy numbers may be at higher risk for Type 2 diabetes, depending on their starch consumption. However, further research is required to explore diet control, long-term follow-up, and a large number of participants to verify these findings and their clinical applications.

“I suspect that people with a lower copy number are at higher risk for Type 2 diabetes,” said Angela Poole, assistant professor of molecular nutrition at Cornell University. "If you knew you had an increased risk of diabetes from day one, it may affect your daily choices, your life choices earlier on where you could prevent it from developing later in life."


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.